The competition, held during the Foundation's Pipeline Conference, awarded prizes across two distinct categories. Jainu Jogani of the Child's Cure Genetic Research Foundation secured the Community Award, receiving up to $50,000 for her research into using allopurinol as a potential treatment for CDKL5 Deficiency Disorder. Meanwhile, the $200,000 Investment Prize went to Sydney Cash of NeuroWeaves, recognized for developing thin, gold-thread EEG electrodes capable of providing hospital-quality monitoring for over 30 days without the need for adhesive.
Epilepsy Foundation Awards $250,000 to Emerging Medical Innovations
Five finalists faced a panel of expert judges in Leesburg, Virginia, last week, competing for a share of $250,000 in funding. The 14th annual Epilepsy Foundation Shark Tank event highlighted advancements ranging from repurposed drug therapies to sophisticated, long-term monitoring technologies for patients living with the chronic brain disorder.
The event also featured pitches from innovators like Brin Freund, who proposed non-invasive neuromodulation techniques, and Deven Sanon, who is developing new anti-seizure medications. The process, modeled after the popular television format, aimed to bridge the gap between early-stage concepts and clinical application. Beyond the competition, the Foundation honored Joyce A. Cramer with the Lifetime Accelerator Award, recognizing her decades of work in clinical trial design and patient-reported outcomes. These investments underscore the organization's ongoing effort to support the 3.4 million Americans currently living with epilepsy.
Comments (0)
No comments yet. Be the first!